Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Where does these shares come from to payout Careoncology?
View:
Post by okletsmakemoney on Aug 18, 2021 3:13pm

Where does these shares come from to payout Careoncology?

Will SZLS pay by the current 61 million shares? or Issue more share to pay?
Comments?
  • 12,400,000 common shares, which will be issued on closing of the Acquisition;
  • 2,500,000 common shares, contingent upon Clinic Operations Limited obtaining a Care Quality Commission licence in the United Kingdom;
  • 8,000,000 common shares contingent upon the achievement of certain milestones ("Milestones") and StageZero
Comment by Liked2Think on Aug 18, 2021 5:42pm
So is this SP priced in already with those diluted shares factored in or not? Likely not so whats the SP when the first 12,400,000 becomes official? $0.30/share by my calc. 8,000,000 common shares contingent upon the achievement of certain milestones (“Milestones”) and StageZero shareholder approval (the “Contingent Shares”). In the event the Milestones are achieved, and the StageZero ...more  
Comment by LithLover on Aug 18, 2021 5:55pm
Stage is issuing 12,400,000 shares at current price of .38 is $4.7 million and they get a company with $4 million in annual revenues.  ROI in just over a year not to mention extra client base, marketing and senior leadership that will be on the board. Company valuation is usually 2 times revenue and if growth is 70% or more should be on the 3x side. So Stage is buying a company that should ...more  
Comment by Liked2Think on Aug 18, 2021 6:08pm
what about the 2,500,000 shares for UK licensing which hey I agree its probably worth that so thats fine. Then the myster 8,000,000 for milestones that we have no idea what they are and if not 8M shares then $16M dollars.  So those milestones are worth $16M or do they think shares will be worth $2 ea by then.  Is this why Tripp wanted the 2:1 RS recently to get the SP to that level? So ...more  
Comment by LithLover on Aug 18, 2021 6:48pm
Omg. I can't fix stupid or teach business to this board. 1. you realize for a private company there are ways to be creative to show a smaller or no profit to avoid tax.  Executive bonus and dividends, asset purchases, employee profit share, acquisitions  etc. Break even does not mean unprofitable. And what is Exas profit to revenue   Lol   You have obviously never ...more  
Comment by Mykndrsn on Aug 18, 2021 7:26pm
Don't waste your efforts trying to educate these boneheads. They're simply not capable, it's a lost cause. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities